Forty years in the field: reproductive biotechnologies shaping genetic progress in cattle in France

Abstract

Abstract Over the past four decades, reproductive biotechnologies have profoundly transformed cattle breeding by accelerating genetic progress and enabling the dissemination of elite genetics. In this article, I present a perspective based on more than 40 years of practical experience in embryo technologies within Auriva-Elevage, a cooperative organization serving 30,000 farmers in southern France. The development of embryo transfer in France was closely linked to genetic and sanitary challenges, particularly the introduction of North American Holstein genetics and the restrictions on live animal imports due to infectious diseases such as Infectious Bovine Rhinotracheitis. These constraints stimulated the development of national expertise in embryo transfer. Over the years, our team has implemented and adapted a wide range of reproductive technologies including in vivo embryo production and embryo transfer, cryopreservation, embryo sexing, ovum pick-up (OPU), in vitro embryo production (IVP), embryo biopsy, genomic evaluation of embryos, and laser-assisted biopsy techniques. The genomic revolution dramatically increased the strategic value of OPU-IVP for the rapid multiplication of elite donor females. In addition to technological developments, the success of these programs has depended heavily on internal training, collaboration with national organizations such as ELIANCE (previously UNCEIA, ALLICE) and research institutes including INRAE and Toulouse veterinary school, as well as strong international exchanges through scientific networks. Practical examples such as the use of embryo biopsy to prevent genetic diseases demonstrate the applied value of these technologies in breeding programs. This review highlights the technical evolution, organizational structures, and human expertise that have shaped the implementation of reproductive biotechnologies in cattle breeding and discusses the importance of anticipating future needs to ensure continued genetic progress.